Mp64-01 predicting risk of side-specific extraprostatic extension in men with prostate cancer using explainable artificial intelligence

Journal of Urology(2021)

引用 0|浏览4
暂无评分
摘要
You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy VI (MP64)1 Sep 2021MP64-01 PREDICTING RISK OF SIDE-SPECIFIC EXTRAPROSTATIC EXTENSION IN MEN WITH PROSTATE CANCER USING EXPLAINABLE ARTIFICIAL INTELLIGENCE Jethro Kwong, Adree Khondker, Christopher Tran, Emily Evans, Amna Ali, Munir Jamal, Thomas Short, Frank Papanikolaou, John Srigley, and Andrew Feifer Jethro KwongJethro Kwong More articles by this author , Adree KhondkerAdree Khondker More articles by this author , Christopher TranChristopher Tran More articles by this author , Emily EvansEmily Evans More articles by this author , Amna AliAmna Ali More articles by this author , Munir JamalMunir Jamal More articles by this author , Thomas ShortThomas Short More articles by this author , Frank PapanikolaouFrank Papanikolaou More articles by this author , John SrigleyJohn Srigley More articles by this author , and Andrew FeiferAndrew Feifer More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002104.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Current machine learning (ML) models are limited by poor interpretability, precluding their routine use in planning nerve-sparing at radical prostatectomy (RP). We aimed to leverage explainable artificial intelligence techniques to provide accurate, interpretable, and personalized predictions for side-specific extraprostatic extension (ssEPE). METHODS: A retrospective sample of 900 prostatic lobes (450 patients) from RP specimens at our institution between 2010 and 2020, was used as the training cohort. Features (ie: variables) included patient demographics, clinical, sonographic, and site-specific data from transrectal ultrasound-guided prostate biopsy. The label (ie: outcome) of interest was the presence of ssEPE in the prostatectomy specimen. A ten-fold stratified cross-validation method was performed to train a gradient-boosted model, optimize hyperparameters, and for internal validation. Our model was further externally validated using a testing cohort of 122 lobes (61 patients) from RP specimens at a separate institution between 2016 and 2020. An existing model from the literature which has the highest performance for predicting ssEPE was selected as the baseline model for comparison. Discriminative capability was quantified by area under receiver-operating-characteristic (AUROC) and precision-recall curve (AUPRC). Clinical utility was determined by decision curve analysis. Shapley Additive exPlanations were used to interpret the ML model’s predictions. RESULTS: The incidence of ssEPE in the training and testing cohorts were 30.7 and 41.8%, respectively. Our model outperformed the baseline model with a mean AUROC of 0.81 vs 0.75 (p<0.01) and mean AUPRC of 0.69 vs 0.60, respectively, on cross-validation of the training cohort. Similarly, our model performed favourably on the testing cohort with an AUROC of 0.81 vs 0.76 (p=0.03) and AUPRC of 0.78 vs 0.72. On decision curve analysis, our model achieved a higher net benefit for threshold probabilities between 0.15 to 0.65. A web application incorporating our model was developed in which de-identified patient data can be inputted to generate an individualized ssEPE prostate map with annotated explanations to highlight which features had the greatest impact on model predictions (www.ssepe.ml). CONCLUSIONS: We have developed a user-friendly application that enables physicians without prior ML experience to assess ssEPE risk and understand the factors driving these predictions to aid surgical planning and patient counselling. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1110-e1110 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jethro Kwong More articles by this author Adree Khondker More articles by this author Christopher Tran More articles by this author Emily Evans More articles by this author Amna Ali More articles by this author Munir Jamal More articles by this author Thomas Short More articles by this author Frank Papanikolaou More articles by this author John Srigley More articles by this author Andrew Feifer More articles by this author Expand All Advertisement Loading ...
更多
查看译文
关键词
prostate cancer,extraprostatic extension,artificial intelligence,predicting risk,side-specific
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要